TABLE 2.
Baseline Characteristics of Randomized Participants in the YES Study (N = 75)*
Characteristics | Exercisers mean ± SD or % |
Usual care mean ± SD or % |
---|---|---|
No. | 37 | 38 |
Age, y | 56.5 (9.5) | 55.1 (7.7) |
Ethnicity | ||
Non-Hispanic White | 84% | 84.0% |
African American | 16% | 11% |
Asian/Pacific Islander | 0% | 3% |
Education (%) | ||
High school graduate | 16% | 22% |
Some school after HS | 24% | 30% |
College graduate+ | 60% | 41% |
Time since diagnosis, y | 3.6 (2.2) | 3.3 (2.6) |
Disease stage (%) | ||
In situ | 11% | 11% |
Stage I | 54% | 27% |
Stage II | 27% | 46% |
Stage IIIA | 8% | 16% |
Type of surgery, % | ||
Lumpectomy | 70% | 54% |
Unilateral mastectomy | 19% | 27% |
Bilateral mastectomy | 11% | 18% |
Treatment, % | ||
None | 5% | 14% |
Radiation only | 41% | 24% |
Chemotherapy only | 19% | 19% |
Radiation and chemotherapy | 35% | 43% |
Hormone therapy | ||
No | 43% | 30% |
Tamoxifen | 30% | 30% |
Aromatase inhibitors | 27% | 40% |
BMI, kg/m2 | 30.4 (6.0) | 30.1 (7.4) |
% Total body fat, DEXA | 41.3 (6.4) | 39.4 (5.9) |
Physical Activity Questionnaire, min/wk recreational exercise | 13.0 (24.0) | 12.0 (20.0) |
Daily Activity Log, min/wk recreational exercise | 30.0 (41.1) | 11.3 (24.8) |
Pedometer steps/d | 5145 (2,312) | 5342 (2,744) |
BMI indicates body mass index; DEXA, dual-energy x-ray absorptiometry.
No statistically significant differences between exercise and usual care groups at baseline.